FDA Expands Vutrisiran Indication to ATTR-Cardiomyopathy ...Middle East

The FDA has approved a supplemental new drug application for the treatment of cardiomyopathy wild-type or hereditary transthyretin-mediated amyloidosis. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Expands Vutrisiran Indication to ATTR-Cardiomyopathy )

Also on site :

• Inside the Target CEO meeting with Black leaders amid the company’s DEI rollback and the boycott that followed
• The Simple Spaghetti Recipe Isabella Rossellini Swears By
• 7 Signs It’s Time to Take Your Memory Issues Seriously